Provided by Tiger Fintech (Singapore) Pte. Ltd.

First Advantage Corp.

14.98
+0.52003.60%
Post-market: 14.980.00000.00%16:05 EDT
Volume:837.57K
Turnover:12.52M
Market Cap:2.60B
PE:-20.18
High:15.05
Open:14.40
Low:14.40
Close:14.46
Loading ...

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

GlobeNewswire
·
18 Feb

Premier League gives green light to semi-automated offsides

cityam
·
13 Feb

First Advantage to Release Fourth Quarter and Full Year 2024 Financial Results and Hold Investor Conference Call on February 27, 2025

GlobeNewswire
·
13 Feb

ROHM’s New General-Purpose Chip Resistors Contribute to Greater Miniaturization

GlobeNewswire
·
13 Feb

First Advantage (FA) Gets a Hold from Needham

TIPRANKS
·
12 Feb

Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks

TipRanks
·
09 Feb

First Advantage Corporation's (NASDAQ:FA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Simply Wall St.
·
08 Feb

Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference

Business Wire
·
04 Feb

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
04 Feb

Innovation Expert Jeremy Gutsche to Keynote First Advantage’s Annual Collaborate Conference

THOMSON REUTERS
·
03 Feb

Innovation Expert Jeremy Gutsche to Keynote First Advantage’s Annual Collaborate Conference

GlobeNewswire
·
03 Feb

Press Release: Mitsubishi Electric India to Acquire Stake in Gervigreind Data Science, Indian Software Startup Company

Dow Jones
·
30 Jan

EE: Home nations agree four-year contract extension with telco

cityam
·
30 Jan

Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich’s Ataxia

GlobeNewswire
·
24 Jan

First Advantage Price Target Maintained With a $22.00/Share by RBC Capital

Dow Jones
·
24 Jan

RBC Capital Remains a Buy on First Advantage (FA)

TIPRANKS
·
23 Jan

Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

GlobeNewswire
·
21 Jan

Investment firm Sixth Street poach FA bigwig of 20 years

cityam
·
17 Jan

Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

GlobeNewswire
·
16 Jan

Here’s what Wall St. experts are saying about these banks ahead of earnings

TIPRANKS
·
15 Jan